Abstract
Background Sexual dysfunction (SD) is a common non-motor symptom (NMS) in people with Parkinson’s disease (PwPD). Sexual health (SH) depends on several biological, mental, and social factors that PD may affect. Despite its prevalence and relevance for quality of life, SD in women with Parkinson’s disease (WwPD) is poorly understood, and research in this area is scarce.
Objectives To investigate the impact of motor, non-motor, and social aspects on the SH of WwPD.
Methods We conducted a cross-sectional study of 100 women (mean age 54.45±8.31, mean H&Y stage 1.70±0.71). The following data were collected for each person (used tests/scales indicated within parentheses and defined in Glossary): (1) demographic information and global cognitive capacity (T-MoCA); (2) non-motor aspects of daily life experiences (MDS-UPDRS, part I); (3) motor aspects of daily life experiences (MDS-UPDRS, part II); (4) fatigue (FSS); (5) self-esteem (RSES); (6) sleep disorder (PDSS); (7) couple relationship quality (CRQ) (DAS); (8) depressive signals (BDI); (8) short-term sexual health (FSFI); and (9) long-term sexual health (SQ-F).
Results Our results suggest that depressive symptoms, preserved cognitive status, and CRQ are predictive factors in the sexual health of WwPD. Age, disease onset, duration, postmenopausal, Levodopa dosage, motor disability, and fatigue were not correlated with SH.
Conclusion Our findings emphasize the need to assess the sexual functioning of WwPD to investigate which motor, non-motor, and social aspects may be involved in SD so that measures can be implemented in clinical practice.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the Ethics Committee of the Federal University of Amapa, Macapa, Brazil (#CAAE 39971420.0.0000.0003) and conducted in accordance with the Helsinki Declaration.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript.